April 8, 2016 | by Denise Heady
When it comes to research into the treatment of blood cancers, City of Hope scientists stand out.
This year, more than 150,000 Americans will be diagnosed with leukemia, lymphoma or myeloma. While survival rates for these blood cancers have climbed steadily in recent decades, researchers at City of Hope are honing even further their ability to fight these cancers, particularly through targeted immunotherapy and its nationally recognized bone marrow transplantation (BMT) program.
Last year, the National Marrow Donor Program recognized City of Hope’s BMT program as exceeding outcome expectations for its patients for the 11th year in a row — the only such program in the nation to have done so over this length of time.
Even with these research advancements and positive patient outcomes, many people still don't associate some of the most common blood cancer symptoms and risks to these types of cancers.
On a recent segment of “KTLA 5 Morning News,” City of Hope neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., discussed a few important blood cancer basics: how blood cancers differ from other cancers, the symptoms not to ignore and how City of Hope is pioneering the treatment of blood cancers through bone marrow transplantation.
If you are looking for a second opinion or consultation about your treatment, request an appointment online or contact us at 800-826-HOPE. Please visit Making Your First Appointment for more information.